PIK3R2 and neoplasm: We have tested the consequences of depleting PIK3R2 only in lung SQCC lines; it is possible that other tumor types showing enhanced PIK3R2 expression at advances phases, such as breast and colon carcinoma or melanoma [24, 25], might also benefit from a therapeutic strategy based on PIK3R2 depletion.